|
Hypertension, sponsored by Pfizer Inc and
its subsidiaries in Latin America which provided an unrestricted grant
to support this initiative.
Via random sampling the study recruited
11,550 individuals, ages 25 to 64, from Bogotá (Colombia), Buenos Aires
(Argentina), Lima (Peru), Mexico City, Quito (Ecuador), Santiago
(Chile), and Barquisimeto (Venezuela) to be representative of the
population of their respective cities. Each of these individuals
completed an interview in his or her home and then visited a medical
center where physical and biochemical measures where obtained. All
participants also had carotic intima media thickness (IMT) measured by
echography.
The objectives of the CARMELA Study were to determine the prevalence of
arterial hypertension, diabetes and dislipidemia, their correlations and
associations; measure the IMT of carotid arteries, investigating its
association with risk factors; evaluate socio-economic factors;
determine other cardiovascular risk factors including tobacco use, diet
and physical activity; and evaluate the pertinent treatment of the
evaluated risk factors and adherence to them.
The CARMELA Study is representative of the city population were the
evaluation was conducted and of the large urban centers of each of the
countries taking part in the survey.
For questions about this study, please contact Dr. Herman Schargrodsky,
Principal Investigator, at
bubyscha@fibertel.com.ar. |
